RCKT
RCKT
US77313F1066
Rocket Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
281.02M EUR
374.62M EUR
390.66M EUR
380.2M EUR
Enterprise Value
29.76M EUR
174.92M EUR
365.82M EUR
327.52M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.97x
--
--
--
Price to Sales
--
--
--
--
Price to Book
0.76x
1.02x
1.64x
1.37x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.16x
--
--
--
Price to FCF (P/FCF)
3.26x
--
--
--
EV/FCF
0.35x
--
--
--
FCF Yield
30.65%
-45.48%
-46.02%
-35.32%
ende